John B Henneman Iii Aprea Therapeutics, Inc. (APRE) insider trading activity

John B Henneman Iii is Director of Aprea Therapeutics, Inc.. Currently has a direct ownership of 10,229 shares of APRE, which is worth approximately $18,514. The most recent transaction as insider was on Jun 05, 2025, when has been sold 1,045 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.2K

11.38% 3M change

25.68% 12M change

Total Value Held $18,514

JOHN B HENNEMAN III Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 05 2025	BUY Grant, award, or other acquisition	-	1,045 Added 9.27%	10,229 Common Stock
Jun 20 2024	BUY Grant, award, or other acquisition	-	1,045 Added 10.22%	9,184 Common Stock
Mar 13 2024	BUY Open market or private purchase	$50,009 $7.29 p/Share	6,860 Added 45.74%	8,139 Common Stock
Aug 23 2023	BUY Grant, award, or other acquisition	-	500 Added 28.11%	1,279 Common Stock
Jul 28 2022	BUY Grant, award, or other acquisition	-	5,995 Added 27.75%	15,605 Common Stock
Jun 30 2021	BUY Grant, award, or other acquisition	-	4,610 Added 32.42%	9,610 Common Stock

Also insider at

ANIK

Anika Therapeutics, Inc. Healthcare

Director

SPNE

SeaSpine Holdings Corp Healthcare

Director

RCM

R1 RCM Inc. Healthcare

OFIX

Orthofix Medical Inc. Healthcare

JBH